Active ingredients Isorhamnetin of Croci Srigma inhibit stomach adenocarcinomas progression by MAPK/mTOR signaling pathway

Gastric cancer (GC) remains the third leading cause of cancer-related mortality in the world, and ninety-five percent of GC are stomach adenocarcinomas (STAD). The active ingredients of Croci Stigma, such as Isorhamnetin, Crocin, Crocetin and Kaempferol, all have antitumor activity. However, their c...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Xue-feng, Yu, Qi, Wang, Kai-bo, Fu, Yi-dong, Zhang, Shun, Liao, Zhen-yun, Li, Yan, Cai, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400561/
https://www.ncbi.nlm.nih.gov/pubmed/37537191
http://dx.doi.org/10.1038/s41598-023-39627-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400561/
https://www.ncbi.nlm.nih.gov/pubmed/37537191
http://dx.doi.org/10.1038/s41598-023-39627-z

Ejemplares similares